Bacterial extracellular vesicle ssRNA prevents colorectal cancer progression via Piezo1

Takeshi Kondo1, Yasunori Takayama2, Yutaro Kumagai3

  • 1Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8636, Japan.

Cell Reports
|December 19, 2025
PubMed

Insights

Bacterial single-stranded RNA (ssRNA) in fecal extracellular vesicles suppresses colorectal cancer (CRC) by activating the Piezo1 channel. Ursodeoxycholic acid enhances this effect, offering a potential therapeutic strategy for CRC.

Area of Science:

  • Gastroenterology
  • Oncology
  • Molecular Biology

Background:

  • Single-stranded RNA (ssRNA) activates the Piezo1 channel in the gut.
  • The source and function of ssRNA in colorectal cancer (CRC) are not well understood.

Purpose of the Study:

  • To investigate the role of bacterial ssRNA within fecal extracellular vesicles (FEVs) in CRC progression.
  • To explore the ssRNA-Piezo1 axis as a potential therapeutic target for CRC.

Main Methods:

  • Utilized gut-specific Piezo1-knockout mice and Piezo1-deficient CRC cell lines.
  • Analyzed the effect of ursodeoxycholic acid (UDCA) on FEV rupture and ssRNA release.
  • Investigated the molecular mechanisms involving Zfp281 and Wnt/β-catenin signaling.

Main Results:

  • Bacterial ssRNA in FEVs suppresses CRC progression through Piezo1 activation.
  • Piezo1 deficiency in mice and cell lines led to increased tumor development and proliferation.
  • Piezo1 activation downregulates Zfp281, reducing Lgr5 expression and Wnt/β-catenin signaling.
  • UDCA treatment enhanced FEV rupture, increased luminal ssRNA, and mitigated CRC in a high-fat diet model.

Conclusions:

  • The bacterial ssRNA-Piezo1 axis is a critical suppressor of CRC.
  • UDCA enhances FEV rupture, increasing protective ssRNA and reducing CRC.
  • Targeting the ssRNA-Piezo1 pathway presents a novel therapeutic avenue for colorectal cancer.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.5K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K